Form 4: Larimar Therapeutics COO Receives Stock Grant
Insider Transaction (Form 4)
John B. Harlow Jr., President and COO of Larimar Therapeutics, Inc., reported multiple transactions in common stock on September 29, 2026.
Summary
- Grant/award: acquired 50,000 Common Stock on September 29, 2026; holds 50,000 after (Direct).
- Grant/award: acquired 800,000 Stock Option (Right to Buy) on September 29, 2026; holds 800,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John B. Harlow Jr. — Officer (President and COO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-29 | Grant/award | Common Stock | 50,000 | — | — | 50,000 |
| 2026-09-29 | Grant/award | Stock Option (Right to Buy) | 800,000 | — | — | 800,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-29 | Grant/award (50,000 shares) |
| 2026-09-29 | Grant/award (800,000 shares) |
Keywords
insider transaction, Form 4, LRMR, Larimar Therapeutics, Inc., neutral, John B. Harlow Jr.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.